Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Floreane Medical strategy yields budget-beating rise

This article was originally published in Clinica

Executive Summary

French medical implants company Floreane (Trevoux) beat its own fourth quarter and full year 2003-04 sales targets, achieving Euros7m ($8.8m) and Euros22.9m, respectively. Final quarter sales were 16.7% up on the previous year (+19.7% with constant exchange rates), while the full year figure was 21.5% ahead of the 2002-03 total, beating the Euronext-quoted company's own year-end projection by 1.5%.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel